HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J Am Dent Assoc, Vol 133, No 1, 35-44. © 2002 American Dental Association

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BAUM, B. J. Articles by YAMANO, S. Search for Related Content PubMed PubMed Citation Articles by BAUM, B. J. Articles by YAMANO, S. Related Collections Restoratives

COVER STORY
JADA Continuing Education

A revisiting after six years

Background. Gene therapy is an emerging field of biomedicine that has commanded considerable scientific and popular attention. The procedure involves the transfer of genes to patients for clinical benefit. Transferred genes can be used for either reparative or pharmacological purposes.

Overview. In 1995, the first author and a colleague described the potential impact of gene therapy on dentistry, on the basis of initial studies of gene transfer applications to salivary glands, keratinocytes and cancer cells. Their conclusion was that gene therapy would have a significant impact on the nature of dental practice within 20 years. In this article, the authors consider research progress since 1995 and reexamine the earlier conclusion.

Practice Implications. In the past six years, remarkable progress has been made in the field of gene therapy, including seven areas relevant to dental practice: bone repair, salivary glands, autoimmune disease, pain, DNA vaccinations, keratinocytes and cancer. While considerable problems remain, thus impeding the routine clinical use of gene transfer, gene therapy will have a pervasive and significant impact on areas of dental practice that are based in biological science. By 2015, this will translate into practitioners’ having a wide range of novel biological treatment options for their patients.

This article has been cited by other articles:

				J.J. Mao, W.V. Giannobile, J.A. Helms, S.J. Hollister, P.H. Krebsbach, M.T. Longaker, and S. Shi Craniofacial Tissue Engineering by Stem Cells Journal of Dental Research, November 1, 2006; 85(11): 966 - 979. [Abstract] [Full Text] [PDF]

				S. Kyrkanides, P. Kambylafkas, J.H. Miller, and R.H. Tallents Non-primate Lentiviral Vector Administration in the TMJ Journal of Dental Research, January 1, 2004; 83(1): 65 - 70. [Abstract] [Full Text] [PDF]

				A. R. SILVESTRI JR. and I. SINGH The unresolved problem of the third molar: Would people be better off without it? J Am Dent Assoc, April 1, 2003; 134(4): 450 - 455. [Abstract] [Full Text] [PDF]

				P. E. Murray, L. J. Windsor, T. W. Smyth, A. A. Hafez, and C. F. Cox ANALYSIS OF PULPAL REACTIONS TO RESTORATIVE PROCEDURES, MATERIALS, PULP CAPPING, AND FUTURE THERAPIES Critical Reviews in Oral Biology & Medicine, November 1, 2002; 13(6): 509 - 520. [Abstract] [Full Text] [PDF]